MICHELLE GOLDEN: Open Payments
NPI 1104339852 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 30 payments from 17 companies in 2025. Trend: 2023 $424 · 2024 $663 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $73 |
| Indivior Inc. | 3 | $71 |
| Braeburn Inc. | 3 | $53 |
| Hologic Sales and Service, LLC | 2 | $48 |
| Lilly USA, LLC | 3 | $47 |
| Dexcom, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| ABBVIE INC. | 2 | $39 |
| Corcept Therapeutics | 1 | $38 |
| Insulet Corporation | 1 | $32 |
Products named: The Cologuard Plus Collection Kit, SUBLOCADE, BRIXADI, APTIMA, Dexcom G6 Transmitter, AIRSUPRA, VRAYLAR, Korlym.
Industry payments across PA — which companies pay providers there.
